{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:16:43Z","timestamp":1788405403698,"version":"build-2803163510"},"reference-count":175,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jocd.2016.09.005","type":"journal-article","created":{"date-parts":[[2016,12,9]],"date-time":"2016-12-09T15:39:50Z","timestamp":1481297990000},"page":"8-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":222,"title":["Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ"],"prefix":"10.1016","volume":"20","author":[{"given":"Aliya A.","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archie","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Kendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Rizzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Felsenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie K.","family":"McCauley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"O'Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian R.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore L.","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Tetradis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson B.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Brandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Guise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Eastell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne N.","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basel","family":"Masri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Obermayer-Pietsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente L.","family":"Langdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana Al","family":"Dabagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Shawn","family":"Davison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George K.","family":"S\u00e1ndor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Josse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"El Rabbany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique D.","family":"Pierroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riad","family":"Sulimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah P.","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques P.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet","family":"Compston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocd.2016.09.005_bib0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2016.09.005_bib0015","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0020","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0025","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2016.09.005_bib0030","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.joms.2014.10.035","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update and CTX","volume":"73","author":"Schwartz","year":"2015","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0035","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0030-4220(93)90433-5","article-title":"Lingual mandibular sequestration and ulceration","volume":"75","author":"Peters","year":"1993","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0040","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1902\/jop.1997.68.8.758","article-title":"Spontaneous bony exposure: a report of 4 cases of idiopathic exposure and sequestration of alveolar bone","volume":"68","author":"Sonnier","year":"1997","journal-title":"J Periodontol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0045","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.bdj.4801315","article-title":"Oral ulceration: a new and unusual complication","volume":"192","author":"Scully","year":"2002","journal-title":"Br Dent J"},{"key":"10.1016\/j.jocd.2016.09.005_bib0050","first-page":"34","article-title":"Oral and maxillofacial pathology case of the month. Lingual mandibular sequestration and ulceration","volume":"117","author":"Flaitz","year":"2000","journal-title":"Tex Dent J"},{"key":"10.1016\/j.jocd.2016.09.005_bib0055","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1834-7819.2003.tb00011.x","article-title":"Oral ulceration with bone sequestration","volume":"48","author":"Farah","year":"2003","journal-title":"Aust Dent J"},{"key":"10.1016\/j.jocd.2016.09.005_bib0060","first-page":"198","article-title":"Oral and maxillofacial pathology case of the month. Lingual mandibular sequestration with ulceration","volume":"122","author":"Kessler","year":"2005","journal-title":"Tex Dent J"},{"key":"10.1016\/j.jocd.2016.09.005_bib0065","doi-asserted-by":"crossref","first-page":"573","DOI":"10.12968\/denu.2007.34.9.573","article-title":"Lingual mucosal ulceration with mandibular sequestration","volume":"34","author":"Jackson","year":"2007","journal-title":"Dent Update"},{"key":"10.1016\/j.jocd.2016.09.005_bib0070","first-page":"18","article-title":"Spontaneous alveolar bone sequestration. Case reports","volume":"84","author":"Danesh-Meyer","year":"1999","journal-title":"J N Z Soc Periodontol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0075","first-page":"71","article-title":"Persistent painful ulcer of the posterior lingual mandibular mucosa","volume":"4","author":"Peters","year":"2003","journal-title":"J Contemp Dent Pract"},{"key":"10.1016\/j.jocd.2016.09.005_bib0080","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1213\/ANE.0b013e3181e0cdcd","article-title":"Case report: osteonecrosis of the mandible after laryngoscopy and endotracheal tube placement","volume":"111","author":"Almazrooa","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0085","doi-asserted-by":"crossref","first-page":"189","DOI":"10.5177\/ntvt.2013.04.12239","article-title":"[Lingual mandibular osteonecrosis]","volume":"120","author":"de Visscher","year":"2013","journal-title":"Ned Tijdschr Tandheelkd"},{"key":"10.1016\/j.jocd.2016.09.005_bib0090","first-page":"197","article-title":"Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis","volume":"15","author":"Walter","year":"2007","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jocd.2016.09.005_bib0095","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.eururo.2008.06.070","article-title":"Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate","volume":"54","author":"Walter","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0100","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.tripleo.2006.06.004","article-title":"Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management","volume":"102","author":"Ruggiero","year":"2006","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.jocd.2016.09.005_bib0105","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws","volume":"65","author":"Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1747-4477.2009.00213.x","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw\u20142009 update","volume":"35","author":"Ruggiero","year":"2009","journal-title":"Aust Endod J"},{"key":"10.1016\/j.jocd.2016.09.005_bib0115","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0120","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bone.2009.07.011","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation?","volume":"45","author":"Lesclous","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.jocd.2016.09.005_bib0125","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.14219\/jada.archive.2009.0049","article-title":"Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy","volume":"140","author":"Sedghizadeh","year":"2009","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.jocd.2016.09.005_bib0130","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1128\/iai.64.7.2371-2380.1996","article-title":"Bacterially induced bone destruction: mechanisms and misconceptions","volume":"64","author":"Nair","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.jocd.2016.09.005_bib0135","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/rheumatology\/37.10.1095","article-title":"Surface-associated protein from Staphylococcus aureus stimulates osteoclastogenesis: possible role in S. aureus-induced bone pathology","volume":"37","author":"Meghji","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0140","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00774-009-0090-6","article-title":"Bisphosphonate administration prior to tooth extraction delays initial healing of the extraction socket in rats","volume":"27","author":"Hikita","year":"2009","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.jocd.2016.09.005_bib0145","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1749-6632.2010.05835.x","article-title":"Potential pathophysiological mechanisms in osteonecrosis of the jaw","volume":"1218","author":"Landesberg","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jocd.2016.09.005_bib0150","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.archoralbio.2010.11.003","article-title":"Bisphosphonate effects on the behaviour of oral epithelial cells and oral fibroblasts","volume":"56","author":"Ravosa","year":"2011","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0155","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00784-010-0507-6","article-title":"The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes\u2014in vitro study","volume":"16","author":"Pabst","year":"2012","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.jocd.2016.09.005_bib0160","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1158\/1078-0432.CCR-10-1614","article-title":"Effect of zoledronate on oral wound healing in rats","volume":"17","author":"Yamashita","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jocd.2016.09.005_bib0165","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1601-0825.2010.01739.x","article-title":"In vivo effects of zoledronic acid on oral mucosal epithelial cells","volume":"17","author":"Allam","year":"2011","journal-title":"Oral Dis"},{"key":"10.1016\/j.jocd.2016.09.005_bib0170","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJM199903043400914","article-title":"Gamma\/delta T-cell stimulation by pamidronate","volume":"340","author":"Kunzmann","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2016.09.005_bib0175","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood.V96.2.384.013k07_384_392","article-title":"Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma","volume":"96","author":"Kunzmann","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jocd.2016.09.005_bib0180","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1182\/blood.V98.5.1616","article-title":"Vgamma2Vdelta2 T-cell receptor-mediated recognition of aminobisphosphonates","volume":"98","author":"Das","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jocd.2016.09.005_bib0185","first-page":"358","article-title":"Animal models of osteonecrosis of the jaw","volume":"7","author":"Allen","year":"2007","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.jocd.2016.09.005_bib0190","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000151371","article-title":"Bisphosphonates and osteonecrosis of the jaw: moving from the bedside to the bench","volume":"189","author":"Allen","year":"2009","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.jocd.2016.09.005_bib0195","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/jbmr.1479","article-title":"Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension","volume":"27","author":"Papapoulos","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2016.09.005_bib0200","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.3899\/jrheum.100221","article-title":"Bisphosphonate-associated osteonecrosis of the jaw in Ontario: a survey of oral and maxillofacial surgeons","volume":"38","author":"Khan","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0205","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study","volume":"28","author":"Stopeck","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0210","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","article-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study","volume":"377","author":"Fizazi","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jocd.2016.09.005_bib0215","first-page":"6538","article-title":"Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats","volume":"62","author":"Fournier","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.jocd.2016.09.005_bib0220","first-page":"2893","article-title":"Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients","volume":"9","author":"Santini","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jocd.2016.09.005_bib0225","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1089\/jir.2005.25.144","article-title":"Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients","volume":"25","author":"Vincenzi","year":"2005","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.jocd.2016.09.005_bib0230","first-page":"364","article-title":"Pharmacogenetics of bisphosphonate-associated osteonecrosis of the jaw","volume":"3","author":"Marini","year":"2011","journal-title":"Front Biosci (Elite Ed)"},{"key":"10.1016\/j.jocd.2016.09.005_bib0235","first-page":"579","article-title":"A SNP in CYP2C8 is not associated with the development of bisphosphonate-related osteonecrosis of the jaw in men with castrate-resistant prostate cancer","volume":"6","author":"English","year":"2010","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jocd.2016.09.005_bib0240","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2008-04-147884","article-title":"Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis","volume":"112","author":"Sarasquete","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jocd.2016.09.005_bib0245","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","article-title":"Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment","volume":"65","author":"Marx","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0250","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.oraloncology.2008.01.012","article-title":"Collagen telopeptide (serum CTX) and its relationship with the size and number of lesions in osteonecrosis of the jaws in cancer patients on intravenous bisphosphonates","volume":"44","author":"Bagan","year":"2008","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0255","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-0501.2010.01965.x","article-title":"Retrospective study of two biochemical markers for the risk assessment of oral bisphosphonate-related osteonecrosis of the jaws: can they be utilized as risk markers?","volume":"22","author":"Kwon","year":"2011","journal-title":"Clin Oral Implants Res"},{"key":"10.1016\/j.jocd.2016.09.005_bib0260","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.joms.2009.02.004","article-title":"Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws","volume":"67","author":"Kunchur","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0265","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/ID.0b013e3181cec8bc","article-title":"CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part II: a prospective clinical study","volume":"19","author":"Lee","year":"2010","journal-title":"Implant Dent"},{"key":"10.1016\/j.jocd.2016.09.005_bib0270","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11845-011-0790-5","article-title":"A role for C-terminal cross-linking telopeptide (CTX) level to predict the development of bisphosphonate-related osteonecrosis of the jaws (BRONJ) following oral surgery?","volume":"181","author":"O'Connell","year":"2012","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.jocd.2016.09.005_bib0275","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.14219\/jada.archive.2010.0082","article-title":"The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program","volume":"141","author":"Grbic","year":"2010","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.jocd.2016.09.005_bib0280","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/ncpendmet0348","article-title":"Osteonecrosis of the jaw\u2014a potential adverse effect of bisphosphonate treatment","volume":"2","author":"Felsenberg","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.jocd.2016.09.005_bib0285","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","article-title":"Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia","volume":"65","author":"Mavrokokki","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0290","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.joms.2013.06.221","article-title":"Osteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonate","volume":"72","author":"Ulmner","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0295","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","article-title":"Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure","volume":"68","author":"Lo","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0300","article-title":"Evaluation of invasive oral procedures and events in women with postmenopausal osteoporosis treated with denosumab: results from the pivotal phase 3 fracture study extension","volume":"29","author":"Watts","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2016.09.005_bib0305","series-title":"Estimated total post-marketing exposure to denosumab: personal communication","author":"Wagman","year":"2014"},{"key":"10.1016\/j.jocd.2016.09.005_bib0310","article-title":"Findings from denosumab (Prolia\u00ae) post-marketing safety surveillance for atypical femoral fracture, osteonecrosis of the jaw, severe symptomatic hypocalcemia, and anaphylaxis","volume":"29","author":"Geller","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2016.09.005_bib0315","first-page":"395","article-title":"An unusual case of total maxillary sequestration in a diabetic patient","volume":"37","author":"Akinmoladun","year":"2008","journal-title":"Afr J Med Med Sci"},{"key":"10.1016\/j.jocd.2016.09.005_bib0320","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.joms.2012.07.049","article-title":"Osteonecrosis of the jaw onset times are based on the route of bisphosphonate therapy","volume":"71","author":"Fleisher","year":"2013","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0325","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Durie","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2016.09.005_bib0330","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/annonc\/mdm370","article-title":"A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients","volume":"18","author":"Jadu","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0335","doi-asserted-by":"crossref","first-page":"23","DOI":"10.14219\/jada.archive.2008.0016","article-title":"Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714,217 people","volume":"139","author":"Cartsos","year":"2008","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.jocd.2016.09.005_bib0340","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3899\/jrheum.080759","article-title":"Bisphosphonate associated osteonecrosis of the jaw","volume":"36","author":"Khan","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0345","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000201931","article-title":"Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone","volume":"76","author":"Christodoulou","year":"2009","journal-title":"Oncology"},{"key":"10.1016\/j.jocd.2016.09.005_bib0350","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0355","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood-2006-07-033571","article-title":"Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone","volume":"108","author":"Tosi","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jocd.2016.09.005_bib0360","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3816\/CLM.2008.n.013","article-title":"Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: definition and management of the risk related to zoledronic acid","volume":"8","author":"Cafro","year":"2008","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.jocd.2016.09.005_bib0365","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/10428190600977690","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patients","volume":"48","author":"Pozzi","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jocd.2016.09.005_bib0370","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jcms.2007.06.008","article-title":"\u201cBis-phossy jaws\u201d\u2014high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw","volume":"36","author":"Abu-Id","year":"2008","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0375","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/jnci\/djm025","article-title":"Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: a population-based analysis","volume":"99","author":"Wilkinson","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jocd.2016.09.005_bib0380","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1200\/JCO.2008.16.9300","article-title":"Natural history of osteonecrosis of the jaw in patients with multiple myeloma","volume":"26","author":"Badros","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0385","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1200\/JCO.2009.21.9584","article-title":"Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw","volume":"27","author":"Vahtsevanos","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0390","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ctrv.2012.07.002","article-title":"Denosumab in patients with cancer and skeletal metastases: a systematic review and meta-analysis","volume":"39","author":"Peddi","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jocd.2016.09.005_bib0395","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1016\/j.ejca.2012.08.002","article-title":"Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials","volume":"48","author":"Lipton","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jocd.2016.09.005_bib0400","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(11)61226-9","article-title":"Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial","volume":"379","author":"Smith","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jocd.2016.09.005_bib0405","first-page":"2035","article-title":"RANK ligand inhibition in bone metastatic cancer and risk of osteonecrosis of the jaw (ONJ): non bis in idem?","volume":"19","author":"Van den Wyngaert","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jocd.2016.09.005_bib0410","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11282-013-0135-3","article-title":"Radiographic findings of bisphosphonate-related osteomyelitis of the jaw: investigation of the diagnostic points by comparison with radiation osteomyelitis, suppurative osteomyelitis, and diffuse sclerosing osteomyelitis","volume":"29","author":"Suei","year":"2013","journal-title":"Oral Radiol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0415","series-title":"Oral radiology","author":"White","year":"2008"},{"key":"10.1016\/j.jocd.2016.09.005_bib0420","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tripleo.2007.01.040","article-title":"Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer","volume":"104","author":"Bianchi","year":"2007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.jocd.2016.09.005_bib0425","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00784-009-0293-1","article-title":"Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study","volume":"14","author":"Stockmann","year":"2010","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.jocd.2016.09.005_bib0430","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tripleo.2007.08.040","article-title":"Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology","volume":"105","author":"Bedogni","year":"2008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.jocd.2016.09.005_bib0435","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00784-009-0311-3","article-title":"Bisphosphonate-related osteonecrosis of the jaw: clinical correlations with computerized tomography presentation","volume":"14","author":"Elad","year":"2010","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.jocd.2016.09.005_bib0440","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/RCT.0b013e318227a81d","article-title":"Bone-within-bone appearance: a red flag for biphosphonate-associated osteonecrosis of the jaw","volume":"35","author":"Fatterpekar","year":"2011","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.jocd.2016.09.005_bib0445","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3174\/ajnr.A0518","article-title":"Imaging findings of bisphosphonate-associated osteonecrosis of the jaws","volume":"28","author":"Phal","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0450","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11282-012-0114-0","article-title":"Recognition of bisphosphonate-related osteonecrosis of the jaw among oral and maxillofacial radiologists: results from a questionnaire-based survey in Japan","volume":"29","author":"Taguchi","year":"2013","journal-title":"Oral Radiol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0455","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/RCT.0b013e31817e4986","article-title":"Imaging findings of bisphosphonate-related osteonecrosis of the jaw with emphasis on early magnetic resonance imaging findings","volume":"33","author":"Krishnan","year":"2009","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.jocd.2016.09.005_bib0460","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1259\/dmfr\/27458726","article-title":"Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws","volume":"35","author":"Chiandussi","year":"2006","journal-title":"Dentomaxillofac Radiol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0465","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11282-013-0124-6","article-title":"Role of magnetic resonance imaging in diagnosis of bisphosphonate-related osteonecrosis of the jaw","volume":"29","author":"Ariji","year":"2013","journal-title":"Oral Radiol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0470","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2478\/v10019-010-0032-x","article-title":"Imaging findings in bisphosphonate-induced osteonecrosis of the jaws","volume":"44","author":"Popovic","year":"2010","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0475","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1200\/JCO.2005.04.2465","article-title":"Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors","volume":"24","author":"Badros","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0480","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0022034510397196","article-title":"Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN","volume":"90","author":"Barasch","year":"2011","journal-title":"J Dent Res"},{"key":"10.1016\/j.jocd.2016.09.005_bib0485","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/0022034510387795","article-title":"ONJ in two dental practice-based research network regions","volume":"90","author":"Fellows","year":"2011","journal-title":"J Dent Res"},{"key":"10.1016\/j.jocd.2016.09.005_bib0490","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.oraloncology.2010.11.007","article-title":"Surgery-triggered and non surgery-triggered Bisphosphonate-related Osteonecrosis of the Jaws (BRONJ): a retrospective analysis of 567 cases in an Italian multicenter study","volume":"47","author":"Vescovi","year":"2011","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0495","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00198-012-2013-y","article-title":"Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures","volume":"24","author":"Lapi","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2016.09.005_bib0500","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2141.2006.06230.x","article-title":"Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients","volume":"134","author":"Zervas","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0505","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1359\/jbmr.080205","article-title":"Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates","volume":"23","author":"Hoff","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2016.09.005_bib0510","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.joms.2007.11.032","article-title":"Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: a case-control study","volume":"66","author":"Wessel","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0515","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/annonc\/mdl408","article-title":"Assessment of renal toxicity and osteonecrosis of the jaws in patients receiving zoledronic acid for bone metastasis","volume":"18","author":"Aguiar","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0520","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1200\/JCO.2008.16.2768","article-title":"Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients","volume":"26","author":"Kyrgidis","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0525","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.joms.2013.02.016","article-title":"Oral health risk factors for bisphosphonate-associated jaw osteonecrosis","volume":"71","author":"Tsao","year":"2013","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0530","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/COC.0b013e3182155fcb","article-title":"A retrospective study evaluating frequency and risk factors of osteonecrosis of the jaw in 576 cancer patients receiving intravenous bisphosphonates","volume":"35","author":"Thumbigere-Math","year":"2012","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0535","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ijom.2011.02.002","article-title":"Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw","volume":"40","author":"Katz","year":"2011","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0540","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1080\/10428190802483778","article-title":"Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates","volume":"49","author":"Montefusco","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jocd.2016.09.005_bib0545","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1834-7819.2008.00078.x","article-title":"The oral health status of patients on oral bisphosphonates for osteoporosis","volume":"53","author":"Kunchur","year":"2008","journal-title":"Aust Dent J"},{"key":"10.1016\/j.jocd.2016.09.005_bib0550","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.oraloncology.2012.03.009","article-title":"Tooth extraction in patients on zoledronic acid therapy","volume":"48","author":"Mozzati","year":"2012","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0555","first-page":"b147","article-title":"Preventive strategies and clinical implications for bisphosphonate-related osteonecrosis of the jaw: a review of 282 patients","volume":"77","author":"Bonacina","year":"2011","journal-title":"J Can Dent Assoc"},{"key":"10.1016\/j.jocd.2016.09.005_bib0560","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.joms.2010.10.055","article-title":"Preventive protocol for tooth extractions in patients treated with zoledronate: a case series","volume":"69","author":"Ferlito","year":"2011","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0565","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/annonc\/mdr039","article-title":"Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience","volume":"23","author":"Vandone","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0570","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.joms.2009.07.068","article-title":"Tooth extraction in patients taking intravenous bisphosphonates: a preventive protocol and case series","volume":"68","author":"Lodi","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0575","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ygyno.2008.11.029","article-title":"Bisphosphonate-induced osteonecrosis of the jaw (ONJ): incidence and risk factors in patients with breast cancer and gynecological malignancies","volume":"112","author":"Fehm","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0580","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1158\/1078-0432.CCR-07-1430","article-title":"Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw","volume":"14","author":"Raje","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jocd.2016.09.005_bib0585","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.joms.2008.09.015","article-title":"Bisphosphonate-induced osteonecrosis of the jaws, bone markers, and a hypothesized candidate gene","volume":"67","author":"Lehrer","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0590","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.14219\/jada.archive.2011.0108","article-title":"Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the American Dental Association Council on Scientific Affairs","volume":"142","author":"Hellstein","year":"2011","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.jocd.2016.09.005_bib0595","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.joms.2006.10.076","article-title":"Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1\u201334)]","volume":"65","author":"Harper","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0600","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1056\/NEJMoa1005361","article-title":"Teriparatide and osseous regeneration in the oral cavity","volume":"363","author":"Bashutski","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2016.09.005_bib0605","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jbmr.556","article-title":"FRAX underestimates fracture risk in patients with diabetes","volume":"27","author":"Giangregorio","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2016.09.005_bib0610","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00432-010-0953-1","article-title":"Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws","volume":"137","author":"Mucke","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0615","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.oraloncology.2011.02.024","article-title":"Long-term outcomes of surgical resection of the jaws in cancer patients with bisphosphonate-related osteonecrosis","volume":"47","author":"Bedogni","year":"2011","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0620","doi-asserted-by":"crossref","first-page":"971","DOI":"10.14219\/jada.archive.2007.0294","article-title":"The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors","volume":"138","author":"Adornato","year":"2007","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.jocd.2016.09.005_bib0625","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.joms.2009.01.006","article-title":"The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws","volume":"67","author":"Carlson","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0630","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bjoms.2009.01.007","article-title":"Bisphosphonate osteonecrosis: a protocol for surgical management","volume":"47","author":"Markose","year":"2009","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0635","first-page":"2313","article-title":"Surgical management of bisphosphonate-related osteonecrosis of the jaw in oncologic patients: a challenging problem","volume":"31","author":"Eckardt","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jocd.2016.09.005_bib0640","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.joms.2010.07.014","article-title":"Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study","volume":"69","author":"Pautke","year":"2011","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0645","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00508-006-0644-8","article-title":"Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients","volume":"118","author":"Wutzl","year":"2006","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.jocd.2016.09.005_bib0650","first-page":"449","article-title":"Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up","volume":"18","author":"Stockmann","year":"2010","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jocd.2016.09.005_bib0655","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tripleo.2010.04.015","article-title":"The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw","volume":"111","author":"Wilde","year":"2011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.jocd.2016.09.005_bib0660","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/lary.20076","article-title":"Bisphosphonate-related osteonecrosis of the jaw and its associated risk factors: a Belgian case series","volume":"119","author":"Saussez","year":"2009","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jocd.2016.09.005_bib0665","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00198-007-0384-2","article-title":"Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome","volume":"18","author":"Yarom","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2016.09.005_bib0670","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/01.mlg.0000240885.64568.9e","article-title":"Osteonecrosis of the jaw associated with bisphosphonate use: presentation of seven cases and literature review","volume":"117","author":"Mortensen","year":"2007","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jocd.2016.09.005_bib0675","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.joms.2008.12.057","article-title":"Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases","volume":"67","author":"Stanton","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0680","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jcms.2012.01.005","article-title":"Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients","volume":"40","author":"Voss","year":"2012","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0685","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijom.2009.11.014","article-title":"Surgical management of bisphosphonate induced osteonecrosis of the jaws","volume":"39","author":"Williamson","year":"2010","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0690","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.tripleo.2006.09.022","article-title":"Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma","volume":"103","author":"Diego","year":"2007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.jocd.2016.09.005_bib0695","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3899\/jrheum.120810","article-title":"Osteonecrosis of the jaw and nonmalignant disease: is there an association with rheumatoid arthritis?","volume":"40","author":"Lescaille","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0700","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.tripleo.2008.09.021","article-title":"Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases","volume":"107","author":"Alons","year":"2009","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.jocd.2016.09.005_bib0705","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.joms.2010.06.200","article-title":"Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw","volume":"69","author":"Hoefert","year":"2011","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0710","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/scs.0b013e3180f611ef","article-title":"Surgical therapy for osteonecrotic lesions of the jaws in patients in therapy with bisphosphonates","volume":"18","author":"Longobardi","year":"2007","journal-title":"J Craniofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0715","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/00016350600844360","article-title":"Clinical aspects and management of bisphosphonates-associated osteonecrosis of the jaws","volume":"64","author":"Biasotto","year":"2006","journal-title":"Acta Odontol Scand"},{"key":"10.1016\/j.jocd.2016.09.005_bib0720","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.tripleo.2007.01.008","article-title":"Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management","volume":"104","author":"Montebugnoli","year":"2007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.jocd.2016.09.005_bib0725","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.tripleo.2011.07.004","article-title":"A prospective clinical trial for assessing the efficacy of a minimally invasive protocol in patients with bisphosphonate-associated osteonecrosis of the jaws","volume":"112","author":"Moretti","year":"2011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.jocd.2016.09.005_bib0730","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1634\/theoncologist.2008-0091","article-title":"Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy","volume":"13","author":"Estilo","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.jocd.2016.09.005_bib0735","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1601-0825.2011.01848.x","article-title":"Antibiotic effects on bacterial profile in osteonecrosis of the jaw","volume":"18","author":"Ji","year":"2012","journal-title":"Oral Dis"},{"key":"10.1016\/j.jocd.2016.09.005_bib0740","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.tripleo.2010.05.067","article-title":"Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series","volume":"110","author":"Epstein","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.jocd.2016.09.005_bib0745","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1600-0714.2011.01095.x","article-title":"Multiple myeloma vs. breast cancer patients with bisphosphonates-related osteonecrosis of the jaws: a comparative analysis of response to treatment and predictors of outcome","volume":"41","author":"Fortuna","year":"2012","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.jocd.2016.09.005_bib0750","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21130","article-title":"Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy","volume":"104","author":"Migliorati","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.jocd.2016.09.005_bib0755","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tripleo.2011.02.037","article-title":"Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center","volume":"112","author":"Nicolatou-Galitis","year":"2011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.jocd.2016.09.005_bib0760","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10103-009-0687-y","article-title":"Surgical approach with Er:YAG laser on osteonecrosis of the jaws (ONJ) in patients under bisphosphonate therapy (BPT)","volume":"25","author":"Vescovi","year":"2010","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.jocd.2016.09.005_bib0765","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10103-009-0654-7","article-title":"Osteonecrosis of the jaws caused by bisphosphonates: evaluation of a new therapeutic approach using the Er:YAG laser","volume":"24","author":"Angiero","year":"2009","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.jocd.2016.09.005_bib0770","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/lsm.20730","article-title":"A preliminary report about treatment of bisphosphonate related osteonecrosis of the jaw with Er:YAG laser ablation","volume":"41","author":"Stubinger","year":"2009","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.jocd.2016.09.005_bib0775","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s10103-011-0974-2","article-title":"Bisphosphonate-related osteonecrosis: laser-assisted surgical treatment or conventional surgery?","volume":"26","author":"Atalay","year":"2011","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.jocd.2016.09.005_bib0780","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/pho.2007.2181","article-title":"Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases","volume":"26","author":"Vescovi","year":"2008","journal-title":"Photomed Laser Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0785","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijom.2010.11.002","article-title":"Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis","volume":"40","author":"Manfredi","year":"2011","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0790","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.oraloncology.2011.08.010","article-title":"Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: a preliminary study","volume":"48","author":"Martins","year":"2012","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0795","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/pho.2010.2835","article-title":"Observation of pain control in patients with bisphosphonate-induced osteonecrosis using low level laser therapy: preliminary results","volume":"29","author":"Romeo","year":"2011","journal-title":"Photomed Laser Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0800","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/pho.2009.2501","article-title":"Effect of low-level laser irradiation on bisphosphonate-induced osteonecrosis of the jaws: preliminary results of a prospective study","volume":"28","author":"Scoletta","year":"2010","journal-title":"Photomed Laser Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0805","first-page":"142","article-title":"Bisphosphonates and osteonecrosis: an open matter","volume":"9","author":"Vescovi","year":"2012","journal-title":"Clin Cases Miner Bone Metab"},{"key":"10.1016\/j.jocd.2016.09.005_bib0810","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.joms.2012.04.001","article-title":"What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics","volume":"70","author":"Freiberger","year":"2012","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0815","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.joms.2007.03.019","article-title":"Hyperbaric oxygen treatment and bisphosphonate-induced osteonecrosis of the jaw: a case series","volume":"65","author":"Freiberger","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0820","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1038\/bcj.2012.9","article-title":"Evolution of bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma and Waldenstrom's macroglobulinemia: a retrospective multicentric study","volume":"2","author":"Andriani","year":"2012","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jocd.2016.09.005_bib0825","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.oraloncology.2011.01.002","article-title":"Efficacy and safety of medical ozone (O(3)) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: preliminary results of a phase I-II study","volume":"47","author":"Ripamonti","year":"2011","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0830","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1097\/01.scs.0000249350.59096.d0","article-title":"New therapeutic protocol in the treatment of avascular necrosis of the jaws","volume":"17","author":"Agrillo","year":"2006","journal-title":"J Craniofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0835","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/scs.0b013e31857261f","article-title":"Ozone therapy in the treatment of avascular bisphosphonate-related jaw osteonecrosis","volume":"18","author":"Agrillo","year":"2007","journal-title":"J Craniofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0840","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jbo.2012.08.001","article-title":"Efficacy and tolerability of medical ozone gas insufflations in patients with osteonecrosis of the jaw treated with bisphosphonates\u2014Preliminary data: medical ozone gas insufflation in treating ONJ lesions","volume":"1","author":"Ripamonti","year":"2012","journal-title":"J Bone Oncol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0845","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.joms.2011.02.078","article-title":"Bisphosphonate-related osteonecrosis of the jaws\u2014an initial case series report of treatment combining partial bone resection and autologous platelet-rich plasma","volume":"69","author":"Curi","year":"2011","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0850","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/SCS.0b013e31824dbdd4","article-title":"Recombinant human bone morphogenetic protein type 2 application for a possible treatment of bisphosphonates-related osteonecrosis of the jaw","volume":"23","author":"Cicciu","year":"2012","journal-title":"J Craniofac Surg"},{"key":"10.1016\/j.jocd.2016.09.005_bib0855","first-page":"1391","article-title":"Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw","volume":"35","author":"Khan","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jocd.2016.09.005_bib0860","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.tripleo.2011.04.020","article-title":"A model for the pathogenesis of bisphosphonate-associated osteonecrosis of the jaw and teriparatide's potential role in its resolution","volume":"112","author":"Subramanian","year":"2011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.jocd.2016.09.005_bib0865","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1746-160X-7-16","article-title":"Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw","volume":"7","author":"Cella","year":"2011","journal-title":"Head Face Med"},{"key":"10.1016\/j.jocd.2016.09.005_bib0870","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-0714.2011.01091.x","article-title":"Bisphosphonates-related osteonecrosis of the jaws: a concise review of the literature and a report of a single-centre experience with 151 patients","volume":"41","author":"Vescovi","year":"2012","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.jocd.2016.09.005_bib0875","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.clbc.2011.02.001","article-title":"Osteonecrosis of the jaw: dental outcomes in metastatic breast cancer patients treated with bisphosphonates with\/without bevacizumab","volume":"11","author":"Ngamphaiboon","year":"2011","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.jocd.2016.09.005_bib0880","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.oraloncology.2011.12.004","article-title":"Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: a report of 32 cases","volume":"48","author":"Mozzati","year":"2012","journal-title":"Oral Oncol"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695016301962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695016301962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:41:10Z","timestamp":1761082870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094695016301962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":175,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1094695016301962"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2016.09.005","relation":{},"ISSN":["1094-6950"],"issn-type":[{"value":"1094-6950","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2016.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Copyright 2017 by The International Society for Clinical Densitometry","name":"copyright","label":"Copyright"}]}}